GIPR[Biotin], His & Avi, Human
GIPR[Biotin], His & Avi, Human

The purity of GIPR[Biotin], His & Avi, Human is greater than 95% as determined by SEC-HPLC.

GIPR[Biotin], His & Avi, Human

GIPR[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

GIPR[Biotin], His & Avi, Human

The gastric inhibitory polypeptide receptor (GIPR), a G protein-coupled receptor (GPCR) that regulates glucose metabolism and insulin secretion, is a target for the development of therapeutic agents to address type 2 diabetes and obesity.
Z04472
¥123,118.00

Ask us a question
Product Introduction
Species Human
Protein Construction
GIPR (Gly26-Gln138)
Accession # P48546-1		 His Avi
N-term C-term
Conjugate Biotin
Purity > 95% as determined by Bis­Tris PAGE 
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 15.88 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 28-38 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • GIPR[Biotin], His & Avi, Human
    • GIPR[Biotin], His & Avi, Human

    The purity of GIPR[Biotin], His & Avi, Human is greater than 95% as determined by SEC-HPLC.

  • GIPR[Biotin], His & Avi, Human
    • GIPR[Biotin], His & Avi, Human

    GIPR[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background The gastric inhibitory polypeptide receptor (GIPR), a G protein-coupled receptor (GPCR) that regulates glucose metabolism and insulin secretion, is a target for the development of therapeutic agents to address type 2 diabetes and obesity.
Synonyms GIP-R; GIPR; PGQTL2

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.